Xi Tan

11PUBLICATIONS
20CO-AUTHORS
Molecular targetsNutrigenomics and personalised nutritionPharmacogenomicsTraditional Chinese medicine and treatmentsDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 20, 2026
Predicting Treatment Failure With Sodium-Glucose Cotransporter-2 Inhibitors in People With Type 2 Diabetes: Novel Artificial Intelligence and Machine Learning Approach.

|Apr 30, 2026
Cardiometabolic and Renal Outcomes in Semaglutide Users with Type 2 Diabetes Achieving Glycemic and Weight Goals: An Observational Cohort Study.

|Jan 09, 2026
Comparison of cardiovascular outcomes between once-weekly semaglutide and dulaglutide in adults with type 2 diabetes and established atherosclerotic cardiovascular disease in the United States.

Xi Tan, Yuanjie Liang, Lin Xie

|May 16, 2025
Healthcare Resource Utilization and Costs in Individuals Who Discontinue Liraglutide and Who Switch from Liraglutide to Once-Weekly Injectable Semaglutide.

Xi Tan, Brenna L Brady, Lin Xie

|May 09, 2025
Macrovascular and microvascular complications in US Medicare enrollees with type 2 diabetes with and without atherosclerotic cardiovascular disease.

Tyler J Dunn, Xi Tan, Joanna Harton

|Oct 10, 2024
Comparing Machine Learning and Advanced Methods with Traditional Methods to Generate Weights in Inverse Probability of Treatment Weighting: The INFORM Study.

Doyoung Kwak, Yuanjie Liang, Xu Shi

Pageof 2

Frequent Collaborators

1 joint publications

Kamlesh Khunti

1 joint publications

Swapnil Rajpathak

1 joint publications

Miao Yu

1 joint publications

Boshu Ru